TP53 and leukemia: Across the leukemia cell lines with TP53 alteration, the median drug-induced cell death changed from 5 ± 5% with 0.5 ng/mL of CLM to 7 ± 7% with the addition of 2.5–10 μM of veliparib (Supplementary Figure S7).